These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 5294603)
1. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis. Shimamoto T; Atsumi T Jpn Heart J; 1965 Sep; 6(5):407-15. PubMed ID: 5294603 [No Abstract] [Full Text] [Related]
2. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease]. Seghezzi R; Pedroni G; Borri P Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600 [No Abstract] [Full Text] [Related]
3. [Effect of pyridinolcarbamate on blood coagulation and thrombolysis in patients with arteriosclerosis obliterans]. Hess H; Goossens N; Keil-Kuri E; Zollner R; Meyer A Vasa; 1972; 1(3):206-11. PubMed ID: 5076123 [No Abstract] [Full Text] [Related]
4. Treatment of occlusive diseases of the arteries in the limbs with pyridinol-carbamate. Matsumoto K; Sato K; Tanaka S Jpn Heart J; 1966 Jan; 7(1):87-93. PubMed ID: 5295647 [No Abstract] [Full Text] [Related]
16. [Treatment of atherosclerosis by pyridinolcarbamate. Review of the history of the introduction of pyridinolcarbamate and its clinical results]. Shimamoto T Rev Atheroscler (Paris); 1968; 10(3):67-84. PubMed ID: 5746502 [No Abstract] [Full Text] [Related]
17. Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans. Shimamoto T; Atsumi T; Yamashita S; Motomiya T; Isokane N; Ishioka T; Sakuma A Am Heart J; 1970 Jan; 79(1):5-19. PubMed ID: 4903137 [No Abstract] [Full Text] [Related]
18. [Current news in the pharmacological and surgical treatment of chronic, peripheral, obliterating arterial diseases of the lower limbs]. Argenteri A; Bagliani A; Borri P; Ugolini U Clin Ter; 1974 Aug; 70(3):281-91. PubMed ID: 4423739 [No Abstract] [Full Text] [Related]
19. Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography. Motomiya T; Atsumi T; Isokane N; Yamashita S; Sano T Jpn Heart J; 1970 Sep; 11(5):433-49. PubMed ID: 4921577 [No Abstract] [Full Text] [Related]
20. [Anticardiolipin antibodies in patients with Buerger's disease]. Cnotliwy M; Gutowski P; Szumiłowicz H; Kucharska E; Jastrzebska M; Ostanek L Wiad Lek; 1999; 52(7-8):332-6. PubMed ID: 10540577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]